Axcan Pharma Inc.

Quebec – Beloeil – Otterburn-Park

Corporation

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Corporation

active

Axcan is a privately-held, leading multinational specialty pharmaceutical company focused on gastroenterology. The Company develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Axcan's products are marketed by its own specialized sales forces in North America and the European Union and through commercial collaborations in many markets around the world.
Country of Ownership: Canada
Exporting: Yes
Primary Industry (NAICS): 325410 - Pharmaceutical and Medicine Manufacturing
Alternate Industries (NAICS): 541710 - Research and Development in the Physical, Engineering and Life Sciences
Primary Business Activity: Manufacturer / Processor / Producer

Products:
Viokase, Salofalk, Urso, urso 250, urso ds, urso forte, Ultrase, Photofrin / photobarr, Panzytrat, Delursan, Carafate / sulcrate, Pylera, Lacteol, Bentyl / bentylol, Proctosedyl, Canasa, Adeks, Cortenema, Modulon, Scandishake, Sulcrate, Flutter, Scandical, Aquadeks, Tagamet, Transulose, Viatol

No associations

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian companies and directors. Rate them and share your experience with other people.

Rating

Axcan Pharma Inc. does not yet have a rating. At this time, there are no reviews or comments for this company.

If you have personal experience with Axcan Pharma Inc., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Axcan Pharma Inc. will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-COD-O-27606

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.